Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 16;65(8):e0036021.
doi: 10.1128/AAC.00360-21. Epub 2021 Jul 16.

Genomic Epidemiology of Carbapenemase-Producing Enterobacterales at a Hospital System in Toronto, Ontario, Canada, 2007 to 2018

Alainna J Jamal #  1   2 , Laura F Mataseje #  3 , Victoria Williams  4 , Jerome A Leis  1   4 , Nathalie Tijet  5 , Sandra Zittermann  5 , Roberto G Melano  5 , Michael R Mulvey  3 , Kevin Katz  4 , Vanessa G Allen  4 , Allison J McGeer  1   2
Affiliations

Genomic Epidemiology of Carbapenemase-Producing Enterobacterales at a Hospital System in Toronto, Ontario, Canada, 2007 to 2018

Alainna J Jamal et al. Antimicrob Agents Chemother. .

Abstract

At a hospital system (H1) in Ontario, Canada, we investigated whether whole-genome sequencing (WGS) altered initial epidemiological interpretation of carbapenemase-producing Enterobacterales (CPE) transmission. We included patients with CPE colonization/infection identified by population-based surveillance from October 2007 to August 2018 who received health care at H1 in the year before/after CPE detection. H1 reported epidemiological transmission clusters. We combined single nucleotide variant (SNV) analysis, plasmid characterization, and epidemiological data. Eighty-five patients were included. H1 identified 7 epidemiological transmission clusters, namely, A to G, involving 24/85 (28%) patients. SNV analysis confirmed transmission clusters C, D, and G and identified two additional cases belonging to cluster A. One was a travel-related case that was the likely index case (0 to 6 SNVs from other isolates); this case stayed on the same unit as the initially presumed index case 4 months prior to detection of the initially presumed index case on another unit. The second additional case occupied a room previously occupied by 5 cluster A cases. Plasmid sequence analysis excluded a case from cluster A and identified clusters E and F as possibly two parts of a single cluster. SNV analysis also identified a case without direct epidemiologic links that was 18 to 21 SNVs away from cluster B, suggesting possible undetected interhospital transmission. SNV and plasmid sequence analysis identified cases belonging to transmission clusters that conventional epidemiology missed and excluded other cases. Implementation of routine WGS to complement epidemiological transmission investigations has the potential to improve prevention and control of CPE in hospitals.

Keywords: beta-lactamases; carbapenem-resistant Enterobacteriaceae; disease transmission; genomic epidemiology; public health.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Carbapenemase/species of 91 carbapenemase-producing Enterobacterales (CPE) isolates belonging to patients who received health care at H1 from 2007 to 2018. a, One was a KPC/VIM coproducer, and one was a KPC/NDM coproducer.
FIG 2
FIG 2
Single nucleotide variant tree of all carbapenemase-producing Klebsiella pneumoniae (n = 38) (A) and Escherichia coli (n = 26) (B) isolates belonging to patients who received health care at H1 from 2007 to 2018. Transmission clusters are boxed and labeled.
FIG 3
FIG 3
Units that cluster A cases stayed on during their admissions to H1. Cases that stayed on unit A all stayed in unit A’s satellite room for ICU B.
See this image and copyright information in PMC

References

    1. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798. 10.3201/eid1710.110655. - DOI - PMC - PubMed
    1. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, Schlaeffer F, Sherf M. 2009. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30:972–976. 10.1086/605922. - DOI - PubMed
    1. Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H. 2010. An outbreak of infection due to beta‐lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50:364–373. 10.1086/649865. - DOI - PubMed
    1. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55:943–950. 10.1093/cid/cis588. - DOI - PubMed
    1. Kontopoulou K, Protonotariou E, Vasilakos K, Kriti M, Koteli A, Antoniadou E, Sofianou D. 2010. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin. J Hosp Infect 76:70–73. 10.1016/j.jhin.2010.03.021. - DOI - PubMed

Publication types